Comparing Apixaban vs Fondaparinux
| Apixaban | Fondaparinux |
|
|---|
| Apixaban | Fondaparinux |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Apixaban reduces the clotting ability of the blood and is used in the treatment and prevention of several medical conditions associated with blood clots. It does not require monitoring; and an... View more |
Prescription only
Prescribed for Deep Vein Thrombosis Prophylaxis after Abdominal Surgery, Pulmonary Embolism, Deep Vein Thrombosis - Prophylaxis, Deep Vein Thrombosis, Deep Vein Thrombosis Prophylaxis after Hip... View more |
Related suggestions Deep Vein Thrombosis
Deep Vein Thrombosis, Prophylaxis
|
|||||||
| More about Apixaban | More about Fondaparinux | ||||||||
| Ratings & Reviews | |||||||||
|
Apixaban has an average rating of 5.1 out of 10 from a total of 286 ratings on Drugs.com. 34% of reviewers reported a positive effect, while 41% reported a negative effect. |
Fondaparinux has an average rating of 9.1 out of 10 from a total of 9 ratings on Drugs.com. 89% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Apixaban side effects |
View all Fondaparinux side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
Lower cost generic |
||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Fondaparinux prices |
||||||||
| Dosage Forms | |||||||||
|
N/A |
|
||||||||
| Brand Names | |||||||||
| Eliquis | Arixtra, Arixtra 10 mg/dose, Arixtra 5 mg/dose, Arixtra 7.5 mg/dose | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
12 hours |
21 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 394 drugs are known to interact with Apixaban:
|
A total of 170 drugs are known to interact with Fondaparinux:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
December 28, 2012 |
N/A |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
|
|||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.